S&P 500 Futures
(-0.24%) 5 240.25 points

Dow Jones Futures
(-0.09%) 38 195 points

Nasdaq Futures
(-0.39%) 18 534 points

Oil
(-0.47%) $77.54

Gas
(-0.70%) $2.55

Gold
(-0.13%) $2 363.50

Silver
(-0.52%) $31.37

Platinum
(-0.44%) $1 033.40

USD/EUR
(-0.08%) $0.922

USD/NOK
(-0.21%) $10.52

USD/GBP
(0.07%) $0.786

USD/RUB
(0.03%) $90.29

Realtime updates for Ryvu Therapeutics S.A. [RVU.WA]

Exchange: WSE Sector: Healthcare Industry: Biotechnology

Last Updated31 May 2024 @ 05:33

25% discount on Stockinvest.us - Use code: Podcast

0.00% PLN 54.20

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 05:33):

Ryvu Therapeutics S.A., a clinical stage biopharmaceutical company, engages in developing of novel small molecule therapies for treatment in oncology. Its lead candidate, RVU120, is a CDK8 kinase inhibitor with potential for development in hematological malignancies and solid tumors, which is in Phase 1b study for the treatment of acute myeloid leukemia and myelodysplastic syndrome...

Stats
Today's Volume	1 918.00
Average Volume	4 047.00
Market Cap	1.25B
EPS	PLN0 ( 2024-05-15 )
Last Dividend	PLN0 ( N/A )
Next Dividend	PLN0 ( N/A )
P/E	-13.55
ATR14	PLN0.156 (0.29%)

Ryvu Therapeutics S.A. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ryvu Therapeutics S.A. Correlation - Currency/Commodity

-0.75
( moderate negative )

-0.82
( strong negative )

-0.48
( neutral )

-0.52
( weak negative )

-0.55
( weak negative )

0.65
( moderate )

Ryvu Therapeutics S.A. Financials

Annual	2023
Revenue:	PLN46.86M
Gross Profit:	PLN-113.44M (-242.09 %)
EPS:	PLN-4.02

FY	2023
Revenue:	PLN46.86M
Gross Profit:	PLN-113.44M (-242.09 %)
EPS:	PLN-4.02

FY	2022
Revenue:	PLN38.80M
Gross Profit:	PLN21.40M (55.14 %)
EPS:	PLN-4.57

FY	2021
Revenue:	PLN11.19M
Gross Profit:	PLN-2.54M (-22.69 %)
EPS:	PLN-0.965

Financial Reports:

No articles found.

Ryvu Therapeutics S.A. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Ryvu Therapeutics S.A.

Ryvu Therapeutics S.A., a clinical stage biopharmaceutical company, engages in developing of novel small molecule therapies for treatment in oncology. Its lead candidate, RVU120, is a CDK8 kinase inhibitor with potential for development in hematological malignancies and solid tumors, which is in Phase 1b study for the treatment of acute myeloid leukemia and myelodysplastic syndrome. The company's products also include SEL24/MEN1703, a dual PIM/FLT3 kinase inhibitor licensed to the Menarini Group that is in Phase 2 clinical trial for the treatment of acute myeloid leukemia. In addition, its early pipeline candidates include candidates in the area of kinases, cancer metabolism, synthetic lethality, and immuno-oncology. Ryvu Therapeutics S.A. was founded in 2007 and is headquartered in Kraków, Poland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.